From Name:
From Email:
To Name:
To Email:

Optional Message:


Intraperitoneal chemotherapy improves 10-year ovarian cancer survival

from Cancer Network

The use of intraperitoneal (IP) chemotherapy for the treatment of advanced ovarian cancer resulted in a survival benefit that extended beyond 10 years compared with intravenous chemotherapy, according to a pooled analysis of data from the Gynecologic Oncology Group (GOG) protocols 114 and 172. “The long-term survival benefits described in this report may encourage more clinicians to adopt IP chemotherapy in the community,” Devansu Tewari, MD and colleagues wrote in the Journal of Clinical Oncology. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063